← 產業報告目錄
Live Cell Encapsulation Market Size, Share & Trends Analysis Report, By Therapeutic Area (Eye Disorders, Metabolic Disorders, Neurological Disorders, and Oncological Disorders), By Target Disease Indication, By Type of Encapsulation Material, By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-29頁數 180報告編號 INSIGHTACE-4add5f594f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Live Cell Encapsulation Market worldwide was assessed at USD 174.2 Mn. Analysts project it will develop to USD 305.5 Mn by 2034, at a CAGR of 5.9% spanning 2025 to 2034.
The Live Cell Encapsulation sector involves The technique of encasing living cells in a protective matrix or structure is known as "live cell encapsulation." This makes it possible to transplant the cells into the host body without disrupting . This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is bolstered by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Live Cell Encapsulation Market Snapshot
Chapter 4. Global Live Cell Encapsulation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Live Cell Encapsulation Market Industry Trends
4.10. Global Live Cell Encapsulation Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Live Cell Encapsulation Market Segmentation 1: By Therapeutic Area, Estimates & Trend Analysis
5.1. Market Share By Therapeutic Area, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Eye Disorders
5.2.2. Metabolic Disorders
5.2.3. Neurological Disorders
5.2.4. Oncological Disorders
Chapter 6. Live Cell Encapsulation Market Segmentation 2: By Target Disease Indication, Estimates & Trend Analysis
6.1. Market Share by Target Disease Indication, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Target Disease Indication:
6.2.1. Ataxia Telangiectasia
6.2.2. Breast Cancer
6.2.3. Diabetes
6.2.4. Glaucoma
6.2.5. Head and Neck Cancer
6.2.6. Macular Telangiectasia
6.2.7. Metastatic and Non-metastatic Pancreatic Cancer
6.2.8. Parkinson's Disease
6.2.9. Retinitis Pigmentosa
Chapter 7. Live Cell Encapsulation Market Segmentation 3: By Type of Encapsulation Material, Estimates & Trend Analysis
7.1. Market Share by Type of Encapsulation Material, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Encapsulation Material:
7.2.1. Alginate-based Microcapsules
7.2.2. Cellulose Hydrogels
7.2.3. Medical-Grade Plastics
7.2.4. Red Blood Cells
Chapter 8. Live Cell Encapsulation Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Live Cell Encapsulation Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts By Therapeutic Area, 2021-2034
8.2.3. North America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Target Disease Indication, 2021-2034
8.2.4. North America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Encapsulation Material, 2021-2034
8.3. Europe
8.3.1. Europe Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts By Therapeutic Area, 2021-2034
8.3.3. Europe Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Target Disease Indication, 2021-2034
8.3.4. Europe Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Encapsulation Material, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts By Therapeutic Area, 2021-2034
8.4.3. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Target Disease Indication, 2021-2034
8.4.4. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Encapsulation Material, 2021-2034
8.5. Latin America
8.5.1. Latin America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts By Therapeutic Area, 2021-2034
8.5.3. Latin America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Target Disease Indication, 2021-2034
8.5.4. Latin America Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Encapsulation Material, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts By Therapeutic Area, 2021-2034
8.6.3. Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Target Disease Indication, 2021-2034
8.6.4. Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Million) Estimates and Forecasts by Type of Encapsulation Material, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Beta-O2 Technologies
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Blue Diamond Growers, Inc.Diatranz Otsuka
9.2.3. Sernova
9.2.4. ViaCyte
9.2.5. Azellon Cell Therapeutics
9.2.6. EryDel
9.2.7. Erytech Pharma
9.2.8. Gloriana Therapeutics
9.2.9. Living Cell Technologies
9.2.10. MaxiVAX
9.2.11. Neurotech Pharmaceuticals
9.2.12. PharmaCyte Biotech
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們